Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sure a > 100% gan in the next few months. With no late trials (you see the value of news like yesterday). Sure the could get aquired or otherwise partner up. You could also win the lottery.
It can all be pre-arranged. Here's an example of one announced 2 days after shareholder approval, and effective 3 days post-shareholder vote.
LEE, MA--(Marketwired - Dec 30, 2015) - Wave Systems Corp. (NASDAQ: WAVX) announced today that, following shareholder approval at the special Shareholders' meeting on December 28, 2015, the Board of Directors has approved a 1-for-10 reverse split of the Company's common stock. The reverse stock split will be in effect at the commencement of trading Thursday, December 31, 2015.
The reverse split is being implemented for purposes of regaining compliance with the $1.00 per share minimum closing bid price requirement for continued listing on the Nasdaq Capital Market.
Yes pphm was going to own or bankrupt csm. Collect 100's of millonsin damages. In theendpphm likely paid more to attorneys than settlement.
Have you considered that this is a broken penny stock. Breakout? Why? It will take REAL news for a breakout. Partner, trial results (not from failed trial), aquisition, new ceo, new bod.
No one believes there is any potential at pphm. That should be obvious. All the exxperts at hedge funds biottech investment firms, other biotechs, no one is buying it - they could all be wrong and a few retail investors could be right.
Not at all surprised by Garnick silence?
Please ....bavi has yet to show it works. What's to keep out of market.
PPHM closed near low of day on heavy volume. Is that a good sign? Does this mean the word is out on the biomarker moonshot? Guess I will wait for Clay's chart.
The two companies could not be more different or in more different situations. PCLN was a casualty of 911 not management failure, pcln was not funding with dilution/atm sales, pcln did not have a history of earlier RS, pcln ws not below $1 when they did the split they could have stayed listed. But since you like the pcln comparison I assume you expect ppphm to still do a rs after the magical rise above $1 in the next few months.
Priceline did not do a RS to maintain listing. They were over $1 when they did RS. They were hardly in the same situation as pphm - no comparison.
It was said buying pphm under $2 was a sure thing too.
I am pretty confident it will be within 30 days of the vote.
The lid is on. Accumulation is underway so "they" are keeping prices low. Shorts are holding it back. No one else understands the value of bavi. Competitor is quietly gobbling up shares.
Nice day for pphm - though easily could have afternoon selloff. Good day for day traders to sell for sure. Also good day for shorts to load up for the predictable close the gap sell off. Goodbye RS? Hardly.
And no buyers at $.44 just head-fake volume
Please. Every website owner is constantly exposed to hacking. There is nothing on pphm website of value. No cc #'s, no secrets etc. so hacking is for trojan planting and other general nuisance attacks.
Yes I have no doubt money can be made trading pphm. It has some patterns that are reliable, around the quarterly for instance. But that is swing trading for 10-20% - nothing wrong with that if you can pull it off. But pphm getting back over $.50 would require some news - never mind $1. What news could come; no trials are running - no news there, avid revenues - they just blew a quarter (real public mfg. companies do not do this btw) so another division of pphm that is unreliable/un-trustworthy as an investor, results from failed trial - lol, acquisition/investment - sure that would do it. Unfortunately not many suitors for a failed drug with no late stage trial success, and a loosely run manufacturing company with just a few customers.
The difference is that Bavi has been proven to NOT work (better than soc). That is what seems to be ever-missing in your calculus.
A slightly different company then pphm:
SRPT Marketcap: $2.3b
SRPT Institutional Ownership: 72.75%
They are not operating on a cash basis. There inventory also increased. The company has not projected a profit. They will not show profit.
1) The cost of goods sold is also deferred
2) Management is not projecting a profit
3) Of course the market would know it was an anomaly
4) This idea that bb members know something that the market doesn't know is how people are in the underwater pphm tarde.
You don't want profitability until you can sustain it anyway. A one wuarter blip becaused you so hugely botched the prev. Quarter is not very useful.